PLRX
Pliant Therapeutics Inc
1.10$
+1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.6% | +10.6% | +21.2% | -14.5% | -13.9% | -2.2% | -0.2% | -2.5% | -16.3% | -27.7% | -5.7% | – | |
| – | -11.7% | +5.6% | +10.1% | -16.4% | -5.4% | +5.9% | -28.4% | +0.6% | -29.5% | -6.0% | -1.6% | – | |
| – | – | +677.2% | -136.2% | – | -157.4% | – | – | – | – | – | – | – | |
| – | -35.1% | +2,345.9% | -16.2% | -28.4% | -76.7% | +25.4% | -57.3% | -100.0% | – | – | – | – | |
| – | -16.6% | +86.5% | -82.0% | +189.3% | +26.4% | +76.6% | -48.7% | -21.3% | -93.7% | -331.9% | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -68.7% | +9,848.9% | -96.9% | -20.6% | -81.2% | +388.2% | -100.0% | – | -44,915.3% | – | -100.0% | – | |
| – | +103.6% | +819.2% | -166.4% | – | – | – | -124.7% | – | -798.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.